Trade Summary

6 days ago, Laponis Adam, serving as Chief Financial Officer at Twist Bioscience Corp (TWST), sold 2,399 shares at $94.33 per share, for a total transaction value of $226,307.27. Following this transaction, Laponis Adam now holds 110,276 shares of TWST.

This sale represents a 2.13% decrease in Laponis Adam's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, July 9, 2026 and publicly disclosed via SEC Form 4 filing on Monday, July 13, 2026 at 4:05 PM ET, 4 days after the trade was made.

Twist Bioscience Corp operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.